ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

WINT Windtree Therapeutics Inc

5.00
-0.30 (-5.66%)
Apr 30 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.30 -5.66% 5.00 18:58:03
Open Price Low Price High Price Close Price Previous Close
5.38 5.02 5.38 5.065 5.30
more quote information »

Recent News

Date Time Source Heading
4/18/202407:00GLOBEWindtree Therapeutics Announces Reverse Stock Split
4/17/202407:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End..
4/08/202415:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and..
2/16/202416:07EDGAR2Form 8-K - Current report
2/14/202416:23EDGAR2Form S-3 - Registration statement under Securities Act of..
2/14/202415:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202419:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202415:40EDGAR2Form PRE 14A - Other preliminary proxy statements
2/01/202416:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/01/202407:00GLOBEWindtree Renews Agreement with Chang Gung University for..
1/31/202407:40IHNWWindtree Therapeutics Announces Engagement of Strategic..
1/31/202407:00EDGAR2Form 8-K - Current report
1/31/202407:00GLOBEWindtree Therapeutics Announces Engagement of Strategic..
1/25/202408:04IHNWWindtree Eliminates $15 Million Contingent Liability to..
1/25/202407:34EDGAR2Form 8-K - Current report
1/25/202407:30GLOBEWindtree Eliminates $15 Million Contingent Liability to..
1/22/202415:45EDGAR2Form 8-K - Current report
1/17/202407:00GLOBEWindtree Therapeutics Announces License Agreement with Lee’s..
1/17/202406:56EDGAR2Form 8-K - Current report
1/16/202415:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/02/202415:05GLOBEWindtree Therapeutics Announces Reduction In Arrythmias In A..
12/18/202307:00GLOBEWindtree Therapeutics Announces the Start of Patient Dosing..
11/16/202307:00GLOBEWindtree Therapeutics Announces Issuance of New Pure SERCA2a..
11/13/202310:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/09/202315:21EDGAR2Form 8-K - Current report
11/09/202315:15GLOBEWindtree Therapeutics Reports Third Quarter 2023 Financial..
11/09/202315:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/09/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202307:00GLOBEWindtree to Present at the Sidoti Micro Cap Conference on..
10/12/202306:30GLOBEWindtree to Present at the ThinkEquity Conference on October..
10/10/202306:30GLOBEWindtree to Participate in the Lytham Partners Fall 2023..
10/03/202307:00GLOBEWindtree to Present at the Dawson James Small Cap Growth..
9/28/202306:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/27/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/26/202307:48EDGAR2Form 8-K - Current report
9/21/202308:35GLOBEDawson James Securities Announces October Date for 8th..
9/05/202318:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/30/202315:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/29/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/28/202315:15EDGAR2Form 8-K - Current report
8/25/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/23/202307:00GLOBEWindtree Announces Issuance of Composition of Matter Patent..
8/16/202316:19EDGAR2Form 8-K - Current report
8/07/202315:05GLOBEWindtree Therapeutics Reports Second Quarter 2023 Financial..
8/07/202315:02EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock